Welcome to the European Consortium for Emergency Contraception (ECEC)
Founded in 2012, ECEC works to expand knowledge about and access to Emergency Contraception (EC) in Europe, and promotes the standardization of EC service delivery to ensure equitable access across the region. Since 2020, ECEC also works globally to advance access to EC.
EC is the only contraceptive method that can be used after sex, and it provides women with an additional opportunity to prevent a pregnancy.
Through this website, we hope to contribute to generating and sharing knowledge of EC in Europe and globally. Your contributions are essential to helping us achieve this goal, and we encourage you to share EC information about your country by writing to us at ecec [at] eeirh [dot] org.
Go directly to country-by-country information on EC access
Go directly to the online EC counseling tool (The EC wheel)
Latest News
WHO ECO guidelines recommend mifepristone for emergency contraception
23 September 2026. The World Health Organization (WHO) launched today the new Guidelines on Expanding Contraceptive Options (ECO). These provide evidence-based recommendations on contraceptive methods and practices that are not currently included in WHO’s Medical eligibility criteria for contraceptive use (MEC), or that differ from existing WHO practice guidance. Mifepristone as emergency contraception WHO recommends…
Webinar: Expanding access to oral contraceptives through regulatory change
27 October 2026 | 14:00 London | 15:00 Brussels | 16:00 Bucharest The European Consortium for Emergency Contraception (ECEC) and Free the Pill, a project of Ibis Reproductive Health, are convening a webinar on how regulatory change can expand access to oral contraceptives. Recent regulatory changes in the United States and the United Kingdom have…
Mifepristone as emergency contraception: New Cochrane review
September 2026. A new Cochrane review, published on 21 September 2026, adds to the evidence on the effectiveness and safety of mifepristone when used as emergency contraception (EC). The review found that both low- and medium-dose mifepristone EC pills (<25 mg and 25–50 mg, respectively) probably result in fewer pregnancies than levonorgestrel EC. Cochrane Despite…